1. Home
  2. ANGI vs RGNX Comparison

ANGI vs RGNX Comparison

Compare ANGI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • RGNX
  • Stock Information
  • Founded
  • ANGI 1995
  • RGNX 2008
  • Country
  • ANGI United States
  • RGNX United States
  • Employees
  • ANGI N/A
  • RGNX N/A
  • Industry
  • ANGI Advertising
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ANGI Consumer Discretionary
  • RGNX Health Care
  • Exchange
  • ANGI Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • ANGI 626.1M
  • RGNX 661.2M
  • IPO Year
  • ANGI 2017
  • RGNX 2015
  • Fundamental
  • Price
  • ANGI $13.39
  • RGNX $13.08
  • Analyst Decision
  • ANGI Hold
  • RGNX Strong Buy
  • Analyst Count
  • ANGI 8
  • RGNX 7
  • Target Price
  • ANGI $21.33
  • RGNX $30.00
  • AVG Volume (30 Days)
  • ANGI 730.3K
  • RGNX 602.9K
  • Earning Date
  • ANGI 11-04-2025
  • RGNX 11-06-2025
  • Dividend Yield
  • ANGI N/A
  • RGNX N/A
  • EPS Growth
  • ANGI N/A
  • RGNX N/A
  • EPS
  • ANGI 1.20
  • RGNX N/A
  • Revenue
  • ANGI $1,088,722,000.00
  • RGNX $155,782,000.00
  • Revenue This Year
  • ANGI N/A
  • RGNX $198.02
  • Revenue Next Year
  • ANGI $4.89
  • RGNX $2.67
  • P/E Ratio
  • ANGI $11.05
  • RGNX N/A
  • Revenue Growth
  • ANGI N/A
  • RGNX 74.95
  • 52 Week Low
  • ANGI $10.88
  • RGNX $5.04
  • 52 Week High
  • ANGI $27.10
  • RGNX $13.93
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 33.27
  • RGNX 57.58
  • Support Level
  • ANGI $12.95
  • RGNX $12.66
  • Resistance Level
  • ANGI $14.45
  • RGNX $13.93
  • Average True Range (ATR)
  • ANGI 0.49
  • RGNX 0.69
  • MACD
  • ANGI 0.04
  • RGNX -0.05
  • Stochastic Oscillator
  • ANGI 29.20
  • RGNX 57.85

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: